In the News

413 News Items found
An illustration of a samurai and a crab.
In the Lab
Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Dr. Debyani Chakravarty
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Charles Swanton
Q&A
Charles Swanton of Cancer Research UK and University College London was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.
abstract red and blue lines suggestive of metabolic pathways
In the Lab
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
Man and woman in white lab coats looking at test tubes
In the Clinic
Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Dr. Eileen O'Reilly seen smiling in an exam room.
Learn about a new FDA-approved treatment for pancreatic cancer in which MSK experts played a leading role in opening a new world of treatment options.
Antonio Lekhrajmal is seen outdoors with his wife, Maria. He has been successfully treated with checkpoint inhibitors for advanced stomach cancer.
Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.
Dr. Neal Rakesh
Cancer pain is common, even after treatment has ended, so doctors at MSK have developed a number of ways to treat cancer pain and help people get back to their lives. 
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.